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Abstract
The molecular mechanism underlying pluripotency is largely unknown. Here, we provide the first global transcriptional profile of the
state of “stemness” in human embryonic stem cells (HESCs). We have identified a set of 918 genes enriched in undifferentiated HESCs
compared with their differentiated counterparts. These include ligand/receptor pairs and secreted inhibitors of the FGF, TGF/BMP, and
Wnt pathways, highlighting a prevalent role for these pathways in HESCs. Importantly, a significant number of HESCs-enriched genes,
including several signaling components, are found to be intersected with published mouse embryonic stem cell data, indicating that a “core
molecular program” is shared between the two pluripotent stem cells.
© 2003 Elsevier Science (USA). All rights reserved.
Introduction
Stem cells are defined by two fundamental functional
properties, the ability to generate cells of identical proper-
ties (self-renew) and to give rise to differentiated cell types
(Lagasse et al., 2001; Smith, 2001). The differentiation
potential of stem cells has been extensively demonstrated in
the mouse (Kim et al., 2002; Lagasse et al., 2001; Smith,
2001). These studies, together with the discovery of pluri-
potent human embryonic stem cells (HESCs) (Reubinoff et
al., 2000; Thomson et al., 1998), have recently opened the
way to the application of stem-cell therapies in the context
of regenerative medicine.
Recent studies have revealed the transcriptional profile
of various stem cell populations, including mouse embry-
onic (MESCs), neural (NSCs), and human and mouse he-
matopoietic stem cells (HSCs) (Ivanova et al., 2002; Ra-
malho-Santos et al., 2002). These studies have established
that embryonic and adult stem cells are distinct in their
expression profiles, while a few hundred genes are shared,
highlighting the possible common stem cell genetic pro-
gram. Despite these important breakthroughs, there is a lack
of large-scale transcriptional information of HESCs that
could provide access to molecular programs in early human
embryogenesis as well as pluripotency, a potential to con-
tribute to three germ layers. While there are differences in
the responsiveness to extrinsic signals, and in the expression
of various markers between human and mouse embryonic
stem (ES) cells, many properties are likely to be shared in
the pluripotent state (Henderson et al., 2002; Smith, 2001;
Thomson et al., 1998). In order to understand the molecular
mechanisms underlying these properties, we sought to in-
vestigate “stemness” as the molecular status in HESCs, and
core molecular components shared with MESCs.
Materials and methods
Human embryonic stem cell (HESCs) cultures
H1 cells were obtained from WiCell Research Institute
(Madison, WI) (Thomson et al., 1998). Initially cells were
maintained on irradiated mouse embryonic fibroblasts
(MEFs) in human ES medium consisting of 80% Knockout-
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Dulbecco’s modified Eagle’s medium, 20% Knockout se-
rum replacement, 1 mM L-glutamine, 1% nonessential
amino acids, 0.1 mM -mercaptoethanol, and 4 ng/ml basic
FGF (all from Invitrogen, Carlsbad, CA). To obtain pure
HESCs colonies, H1 cells were cultured on Matrigel (BD
biosciences, Bedford, MA) with medium conditioned from
MEFs according to the method established by Xu et al.
(2001). During several passages, H1 cell colonies became
completely free from MEFs. H1 cells grown on Matrigel
showed compact morphology with high nuclear-cytoplas-
mic ratio, even after several passages, similar to that of H1
cells grown on MEFs.
To induce embryoid body formation, H1 cells were har-
vested by using dispase (Invitrogen), plated on nontissue
culture-treated dishes, and grown for 5 days.
To differentiate ES cells into neurons, PA6 stromal cell
line (RIKEN, Japan) was used for a coculture system (Ka-
wasaki et al., 2002). H1 cell colonies grown on Matrigel
were harvested and cultured on PA6 stromal cells in 90%
Knockout-Dulbecco’s modified Eagle’s medium, 10%
Knockout serum replacement, 1 mM L-glutamine, 1% non-
essential amino acids, 0.1 mM -mercaptoethanol for 3
weeks.
For nonlineage directed differentiation, cells were cul-
tured on Matrigel in human ES medium (nonconditioned)
for 26 days.
Immunofluorescence
Cells were fixed in 4% paraformaldehyde for 20 min at
room temperature and incubated with primary antibodies,
SSEA-3 (MC-631, mouse IgM; Developmental Studies Hy-
bridoma Bank, University of Iowa) or Tuj-1 (BAbCO, Rich-
mond, CA) at 4°C overnight. Antigens were localized by
using goat anti-mouse IgM or IgG conjugated to Cy3
(Zymed laboratories Inc., South San Francisco, CA) for
SSEA-3 or Tuj-1, respectively.
RNA isolation
Total RNA was isolated from cells by using Qiashredder
and RNAeasy mini kit (Qiagen, Valencia, CA). The ex-
tracted RNA sample was quantified by UV spectrophotom-
eter and qualified by the RNA Nano Lab chip (Agilent
Technologies, Palo Alto, CA).
Probe preparation and hybridization of Affymetrix DNA
arrays
Five micrograms of total RNA was used for the RT
reaction primed with T7-Oligo(dT) promoter (Affymetrix,
Santa Clara, CA) using SuperscriptII (Invitrogen) and pro-
ceeded to second-strand cDNA synthesis. The double-
stranded cDNA sample was cleaned up by phenol-chloro-
form extractions. Biotin-labeled cRNA was synthesized by
in vitro transcription using Bioarray RNA Transcript Label-
ing Kit (Affymetrix), which includes T7 RNA polymerase
and biotin-labeled UTP and CTP. The biotin-labeled cRNA
sample was cleaned up and quantified by the RNA Nano
Lab chip. Fifteen micrograms of the cRNA product was
fragmented to create 35-200 bases by adding fragmentation
buffer containing trizma base, magnesium acetate, potas-
sium acetate, and glacial acetic acid (all from Sigma, St.
Louis, MO) at 90°C for 35 min. The fragmented cRNA was
mixed with hybridization solution containing Control Oli-
gonucleotide and Hybridization Controls (Affymetrix), and
hybridized to Affymetrix human HG-U133A arrays by in-
cubating at 45°C overnight. The hybridized arrays were
scanned by GeneArray scanner (Affymetrix).
Data analysis
Raw signal analysis
For all arrays, the Affymetrix MAS 5.0 software was
used to normalize the arrays and generate absolute expres-
sion estimate (Signal). These raw results are posted at the
Web site http://xenopus.rockefeller.edu for further analyses.
For the comparison with mouse MESC-enriched genes re-
ported by Ramalho-Santos et al. (2002), we also processed
the raw data with the dCHIP and MAS 4.0 methods, as these
authors use a combination of these methods to define the
MESC-enriched gene lists.
Identification of differentially expressed genes
To estimate the statistical significance of differential
expression between our two groups of three replicates each,
we used regularized t-statistics as described by Baldi and
Long (2001). In our implementation, all Signal values were
first log-transformed and the regularized variances were
taken as reg2  002  n  1s2/0  n  2,
independently for each group of replicates. We used 0  3;
s2 is the sample variance (n  3). 02 denotes the a priori
expected variance for a gene, given its mean intensity, and
is estimated from the data by using an intensity-dependent
regression of sample variance vs sample mean. The means
and variances from both groups were used in the same
regression.
Comparison of human and mouse enriched genes
To find the correspondence between probes on the hu-
man U133A and mouse U74Av2 arrays, we interrogated the
NetAffx (www.netaffx.com) and TIGR database to perform
human–mouse ortholog search. We counted that all probes
on the U133A array contain 6509 unique Human Unigene
Clusters for which mouse probes exist on the U74Av2 array.
Our HESCs-enriched lists of 918 (1026; calculated by
dCHIP and MAS4.0 method) genes contained 541 (respec-
tively 594) of these 6509 Unigene Clusters; and the 1703
MESCs-enriched genes by Ramalho-Santos et al. (2002)
contained 1215 of them. The shared fraction between the
541 and 1215 (respectively 594 and 1215) unique Human
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Unigene Clusters totalized 227 (respectively 249), with an
overlap of 179 between the two sets. We calculated the
significance of our result by using the hypergeometrical
distribution test (Tavazoie et al., 1999) and found P-values
that were far below coincidental overlapping (P  4 
1040, 7.8  1044, and 4.6  1017 for the 227, 249, and
179 cases).
RT-PCR primers and conditions
Two micrograms of total RNA from the same RNA
sample stock that was used for the array analysis was treated
with DNaseI (Invitrogen) to remove potential contamination
of genomic DNA followed by reverse-transcription by using
random hexamer and MMLV-RT (Invitrogen) according to
the manufacturer’s protocol. Fifty nanograms of the result-
ing cDNA was amplified by PCR with gene-specific primers
and 0.1 l [-32P]dATP under the condition includes: 5 min
at 94°C, 15 cycles of: 1 min at 94°C, 1 min at 55°C, 1 min
at 72°C, and finalized by an extension step at 72°C for 10
min. The amplification results were visualized by Phospho-
rImager (Amersham Biosciences, Piscataway, NJ).
The primer sequences used in this experiment are avail-
able from our Web site (http://xenopus.rockefeller.edu/).
Results and discussion
We postulated that genes implicated in the maintenance
of the pluripotent state would be significantly downregu-
lated in the differentiated population. In order to address this
directly, we compared the transcriptional profiles of pluri-
potent HESCs to cells that have been pushed to differenti-
ation, and compared these data with published MESCs data
sets. The outline of the entire experimental process is shown
in Fig. 1 (left). HESCs (H1 line from WiCell Research
Institute) (Thomson et al., 1998) were initially maintained
on irradiated MEFs (Fig. 1A and B), and subsequently
switched to a feeder free culture system by using condi-
tioned medium (CM) prepared from MEFs (Xu et al., 2001).
After several passages under this condition, HESCs became
free from contaminated MEFs, while cells maintained typ-
ical undifferentiated tight morphology (Fig. 1C and D),
which was further confirmed by positive staining for
SSEA-3 (Fig. 1E). To determine the differentiation potential
of HESCs, cells were induced to generate embryoid bodies
(EBs) by plating on bacterial dishes and were able to form
typical EBs comparable to that obtained from HESCs on
MEFs. (Fig. 1F). A lineage-specific differentiation potential
of HESCs was also evaluated by culturing on PA6 stromal
feeder cells in differentiation medium for 3 weeks (Ka-
wasaki et al., 2002). A robust generation of Tuj-1-positive
neurons was observed at the end of the cultivation (Fig. 1G
and H). These results indicate that specific features of plu-
ripotent ES cells were preserved in HESCs grown in the
feeder-free system. To establish differentiated progenies of
HESCs for the array analysis, nonlineage-directed differen-
tiation was induced by growing cells in the same way as in
the feeder-free system, except that they were maintained in
non-CM for 26 days. By the end of the culture period, cells
showed a remarkable flat morphology (Fig. 1I and J) and
lost the potential to form EBs (data not shown). Triplicate
samples were independently prepared from undifferentiated
HESCs maintained in CM or differentiated HESCs grown in
non-CM. Purified RNA samples were processed to generate
cRNA probes and hybridized with HG-U133A arrays, each
of which contains more than 22,200 human transcripts.
The gene expression levels for all experiments were
estimated by using the MAS5.0 algorithm (Signal values).
The statistical significance of expression changes between
the three undifferentiated and three differentiated states was
established by using a regularized t-test following Baldi and
Long (2001). To exclude redundant genes included in array
probe sets, we use Unigene IDs in our analyses.
Using this approach, we identified 918 nonredundant
transcripts that were enriched in pluripotent HESCs (P 
0.01). This represents roughly 9% of all “Present” tran-
scripts (9626) in the undifferentiated HESCs. Of these, 42
genes (4.5%) were called “Absent” in all triplicate sets of
the differentiated H1 population. The results including raw
data of this analysis are posted on our Web site (http://
xenopus.rockefeller.edu/) so that public access is insured for
alternative analysis.
A representative scatter plot of duplicates in the undif-
ferentiated or differentiate state shows high reproducibility
(Fig. 2A, left and middle, respectively), while a comparison
between the two different states highlights differentially
regulated genes, including known ES-related markers (Fig.
2A, right). To confirm the reproducibility of the array data
independently, RT-PCR using gene-specific primers was
performed to verify the changes in expression of transcripts
including enriched genes, upregulated in the differentiated
condition, or internal controls (Fig. 2B). PCR cycles were
determined to amplify the gene products within a linear
range. In all cases tested, we observed a remarkable corre-
lation in differential gene expression levels between RT-
PCR and array data, validating the transcriptional profiling
obtained by our analysis. In addition, a pilot RT-PCR ex-
periment using another type of HESCs (HES3 line from ES
International Pte Ltd.) (Reubinoff et al., 2000) showed sim-
ilar results (data not shown).
All enriched genes are classified by functional anno-
tation (available from http://xenopus.rockefeller.edu/) us-
ing NetAffx, GeneOntology, and OMIM database, and
summarized in Fig. 3A. The most highly enriched genes
sorted by P-value are shown in Fig. 3B. This set includes
genes known to be expressed in early embryogenesis, ES,
or EG cells (Smith, 2001), such as Lefty-A and B,
TDGF1, and Oct-3/4, which provides a positive control
for the quality of the cells. Although the Rex-1 gene is
known to be specific for ES cells, the U-133A chip used
in this study does not include probes matched with the
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published sequence (Henderson et al., 2002). In this anal-
ysis, we have focused on genes enriched in the undiffer-
entiated status. However, it should be noted that a num-
ber of differentiation-related transcripts, including
keratins and alpha-feto protein, were found to be upregu-
lated in the differentiated HESCs (data not shown). These
results suggest that a pool of 918 enriched genes is a
potential source to molecularly define stemness in
HESCs. Importantly, 254 genes out of 918 enriched
genes (28%) correspond to ESTs with no known domain
Fig. 1. Identification of “stemness genes” in human embryonic stem cells (HESCs) and common “stemness genes” between HESCs and mouse embryonic
stem cells (MESCs). (Left) A representative scheme of the data analysis process. RNA samples were purified from undifferentiated and differentiated H1
cells. cRNA probes were prepared from the RNA samples and hybridized to human oligonucleotide array (HG-U133A) chips. The array data were analyzed
by Affymetrix Microarray Suite 5.0 and subjected to the public database search to identify genes enriched in undifferentiated H1 cells. The “human stemness
genes” were intersected to the published MESC-enriched genes to determine common “stemness genes” between mouse and human. (Right) Morphological
and immunocytochemical evaluation of undifferentiated and differentiated H1 cells. (A) A colony of H1 cells grown on irradiated mouse embryonic
fibroblasts (MEFs). (B) High magnification of H1 cells grown on irradiated MEFs. Each cell displays a compact morphology and a high nucleus-cytoplasmic
ratio typical of undifferentiated HESCs. (C) A colony of H1 cells grown on Matrigel in medium conditioned from MEFs after several passages. Note a clear
boundary consisting of undifferentiated morphology of H1 cells and no obvious contamination of MEFs. (D) High-magnification view of H1 cells grown on
Matrigel in conditioned medium. Cells demonstrate a typical undifferentiated morphology with a clear border. (E) H1 cells on Matrigel stained for anti
SSEA-3 antibody. (F) Embryoid bodies were induced from H1 cells and photographed on day 5. (G) Neural induction of H1 cells cultured on PA6 feeder
cells. H1 cells were cultured on PA6 feeder cells for 3 weeks and stained for anti Tuj-1 antibody. (H) High magnification of H1 cells differentiated into
neurons. Tuj-1-positive neurons are induced from H1 cells (I) Differentiation of H1 cells in the absence of conditioned medium. H1 cells were cultured in
the absence of conditioned medium for 26 days. (J) Higher magnification of differentiated H1 cells. Note a flat morphology of H1-derived differentiated cells.
Scale bars: (A, C, F, G, I) 300 m; (B, D, E, H, J) 100 m.
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and function. Further analysis of these genes might reveal
unidentified molecules distinctively expressed in undif-
ferentiated HESCs.
Since signal transduction pathways are known to play
key roles in early embryogenesis and cell fate decisions
(Brivanlou and Darnell, 2002), we have focused on the
transcriptional profile of the major signaling pathways. Sig-
naling-related genes comprise approximately 17% of the
enriched genes (Fig. 3A). Overall, we find that a surpris-
ingly small number of secreted components of the pathways
are enriched in the undifferentiated HESCs. These include
ligand/receptor pairs of the FGF and the TGF/BMP sig-
naling pathways, suggesting that these pathways can be
activated in an autocrine or paracrine fashion (Fig. 3C). In
Fig. 2. (A) Scatter plots of Human GeneChip data. The reproducibility of replicates is shown for both undifferentiated (left, r2  0.95 taken in
log-coordinates) and differentiated states (middle, r2  0.96). The right panel shows the changes between the two states. The means of the three replicates
in each state (U and D ) are plotted. Genes marked in blue are significantly different (P  0.01) according to a regularized t-statistics (Baldi and Long, 2001).
Our enriched set corresponds to the blue genes below the diagonal. Dashed lines show fold change lines of 2 and 3 in both up and down directions.
Representative transcripts known to be expressed in embryonic stem cells are also shown. (B) RT-PCR analysis of undifferentiated and differentiated H1 cells.
Two micrograms of each RNA sample extracted from undifferentiated H1 samples or differentiated H1 samples used for the array experiments was
reverse-transcribed and subjected to PCR with primers specific for genes differentially expressed in the array analysis. The left and middle panels represent
genes downregulated in the differentiated condition, including the undifferentiated status-enriched genes. The top right four panels show genes upregulated
in differentiated H1 cells. G3PD and Actin represent internal controls. For each gene, two representative samples from the undifferentiated (U1 or U2) or
differentiated (D1 or D2) condition are demonstrated.
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Fig. 3. (A) Functional annotation of 918 undifferentiated HESCs-enriched genes. (B) Most significant (sorted by P-value) undifferentiated HESCs-enriched
genes. The respective fold changes are also indicated. The full list can be found in the online supplement. (C) Signaling-related genes enriched in the
undifferentiated state. HESC-enriched genes are functionally annotated, and genes involved in extracellular signaling are categorized by each signaling
pathway.
409N. Sato et al. / Developmental Biology 260 (2003) 404–413
Fig. 4. (A) Intersection between MESC- and HESC-enriched genes. For ideal comparison, we reproduced the analysis used by Ramalho-Santos et al. (marked
by **, uses dCHIP  MAS4.0), in addition to our primary analysis (MAS5.0  Baldi method) indicated by *. Of the 918 genes identified using *, 541 had
mouse orthologs on the MG-U74Av2 array, of which 227 were found in the list by Ramalho-Santos et al. Similarly, when using **, the shared number
between human and mouse genes was 249 and the intersection between the 249 and 227 sets was 179. Of the 1703 MESC-enriched genes, 1215 were found
to have human orthologs on the HG-U133A array. To estimate the probability of the observed overlap between human and mouse sets, we performed the
hypergeometrical distribution test (Tavazoie et al., 1999) and found P-values that were far below coincidental overlapping (P  4  1040, 7.8  1044,
and 4.6  1017 for the 227, 249, and 179 cases respectively). (B) Overlapping genes between undifferentiated HESCs and MESCs-enriched genes sorted
by P-value. A total of 227 genes overlapped between HESC- and MESC-enriched genes identified by using *, are sorted by P-value of HESC-enriched genes,
and the top 20 genes are demonstrated. The full gene list is available from http://xenopus.rockefeller.edu/.
the FGF signaling pathway, FGF2/13 are enriched, together
with FGFR1/2. In addition, FGFR4, a receptor for FGF2/13,
is also found to be closely enriched (P  0.012). While the
genes Sprouty 1/4, negative regulators for FGF signaling,
are also enriched, whether this expression is a result of a
transcriptional response to FGF signaling (Placzek and
Skaer, 1999) or whether their expression acts to limit the
activity of MAPK signaling is unclear. Chimera experi-
ments using FGFR1(/) MESCs or in vitro explant cul-
tures of FGFR2(/) mouse blastocysts have shown severe
impairment of their differentiation potentials (Arman et al.,
1998; Deng et al., 1994). HESCs require the exogenous
FGF2 to maintain the undifferentiated state (Thomson et al.,
1998), and the expression of these components suggests that
endogenous FGF signaling may play an essential role in the
undifferentiated state as well.
Within the BMP pathway, only GDF-3/BMP-R1A are
significantly enriched in the undifferentiated state, although
there are several BMP/GDF ligands and receptors found
to be called “Present” in the undifferentiated HESCs (a list
of all “Present” genes is available from http://xenopus.
rockefeller.edu/). While the physiological role of GDF-3
remains unclear, it is highly expressed in human embryonic
carcinoma (EC) cell lines, and downregulated upon retinoic
acid-induced differentiation (Caricasole et al., 1998). Inter-
estingly, Lefty-A and -B, secreted inhibitory ligands (Schier
and Shen, 2000) in the TGF pathway, are among the most
highly enriched genes in HESCs (cf. a number of secreted
TGF antagonists, including TMEFF, Follistatin-like, and
Cerberus, are found to be called “Present,” but not enriched
in the undifferentiated state). It is of note that Lefty 1, a
mouse homolog of LeftyA, was reported to be one of the
downstream target genes for Oct-3/4, a key transcription
factor in the pluripotent ES cells (Niwa et al., 2000). Al-
though Lefty 2, a mouse homolog of LeftyB, is not required
for the pluripotent state in mice (Meno et al., 1999), the high
expression of Lefty 1 might functionally compensate. Alto-
gether, the existence of these highly enriched secreted in-
hibitors is suggestive that a negative regulation of the TGF
pathway may be critical for the maintenance of the undif-
ferentiated HESCs.
Modulation of Wnt signaling in MESCs can interfere
with their differentiation potential (Aubert et al., 2002;
Kielman et al., 2002). In our data set, Frizzled 5 is the only
Wnt-receptor found to be enriched, while no ligand was
detected. Therefore, this pathway cannot be activated in a
cell-autonomous manner. However, since FRAT2 and Cy-
clin D1, a positive regulator and a transcriptional target for
the Wnt pathway, respectively (Saitoh et al., 2001; Willert
et al., 2002), are enriched, the possibility that a secreted
factor(s) from MEFs activates this pathway could not be
ruled out. In the Hedgehog signaling pathway, although this
pathway has been implicated in early embryonic processes,
we find no enriched genes or ligands called “Present” in the
undifferentiated HESCs.
Despite the differences in the responsiveness to signaling
factors, such as LIF, important for MESCs but not for
HESCs (Thomson et al., 1998), and differentiation poten-
tials including trophoblasts that can be generated from
HESCs, but rarely by MESCs (Smith, 2001; Thomson et al.,
1998; Xu et al., 2002), the molecular programs that underlie
pluripotent stem cell properties are likely conserved evolu-
tionarily (Henderson et al., 2002). However, large-scale
comparative profiling that enables characterization of these
conserved genes has not yet been reported. Two recent
reports have shown that approximately 2000 genes are en-
riched in undifferentiated MESCs (Ivanova et al., 2002)
(Ramalho-Santos et al., 2002). We compared our human
data sets with MESC-enriched genes available from the
Web site (Ramalho-Santos et al., 2002). In order to identify
mouse counterparts for human data sets, we searched the
NetAffx human–mouse orthologs link and TIGR databases.
Of our 918 transcripts, 541 have mouse orthologs on the
MG-U74Av2 array used for the MESCs analysis, of which
227 were found to be shared by the list of MESCs-enriched
transcripts (Ramalho-Santos et al., 2002) (Fig. 4A and B; a
complete list of enriched genes is available from http://
xenopus.rockefeller.edu/). We calculated the significance of
the number of the intersected genes using the hypergeo-
metrical distribution test (Tavazoie et al., 1999) and found
that P-values were far below coincidental overlapping (see
Materials and methods). To ensure that these results were
not flawed by the different statistical methods used for
identifying differentially expressed transcripts, we repro-
duced the analysis used in Ramalho-Santos et al. (2002) [a
combination of dCHIP (Li and Wong, 2001) and MAS4.0]
and found similar results (Fig. 4A). Despite differences in
species and baselines between both sets (HESCs cultured in
the absence of CM for 26 days vs mouse adult brain and
bone marrow tissues), the significance of the fraction of
intersected genes highlights the possibility that a core set of
“stemness” genes is evolutionally conserved. This observa-
tion is further supported by a recent report showing that
39% of mouse HSCs-related genes are enriched in human
fetal HSCs (Ivanova et al., 2002).
Notably, signaling-related genes including the TGF/
BMP members Lefty and GDF3/BMP-R1A are also found
to be enriched (12.3%) in the human–mouse intersection,
suggesting essential roles for the TGF/BMP signaling
pathway in the maintenance of stemness. A recent report
demonstrated that a higher proportion of MESCs tend to
adopt preneural fates in specific conditions where the BMP
signaling is inhibited (Tropepe et al., 2001), consistent with
the default model of neural specification initially established
in frogs (Munoz-Sanjuan and Brivanlou, 2002). Therefore,
BMP/GDF signaling might be at the core of stem-cell prop-
erties across the species. While no exact match of molecules
in the FGF signaling pathway was found in the intersection,
as several components including FGF4, whose mutant mice
failed to maintain the ICM, were enriched in MESCs (Feld-
man et al., 1995), this pathway is likely to be also important
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for both species. Since it is possible that an unidentified
signaling molecule(s) might also play a role in pluripotent
ES cells (Smith, 2001), ESTs and genes of unknown func-
tions sharing 17% of the human–mouse intersection need to
be evaluated.
Recent studies have revealed that MESCs are capable of
reprogramming somatic nuclei upon cell fusion reminiscent
of nuclear reprogramming by oocytes, presenting another
specific functional property of the pluripotency (Tada et al.,
2001). Although molecular mechanisms that operate this
function are unknown, the chromatin-remodeling machin-
ery, one of whose main components enriched in the human–
mouse intersection, may play a role in resetting the epige-
netic status of the somatic nuclei (Kikyo et al., 2000). More
recently, it has been shown that this machinery can be
regulated by the inositol signaling pathway (Shen et al.,
2003). Together with the fact that the activity of phospha-
tidylinositol 3 (PI3)-kinase, which also interacts with phos-
pholipase C (Piccolo et al., 2002), is necessary for prolif-
eration and differentiation potentials of MESCs (Chen et al.,
2000; Jirmanova et al., 2002), and main components of this
pathway including inositol-monophosphatases and PI3 ki-
nase are enriched in the human–mouse intersection and
HESCs, respectively, there might be a possibility that this
pathway is involved in the molecular programs specific for
pluripotent ES cells through interacting with the remodeling
machinery.
The remaining 691 human stemness genes not over-
lapped with MESC-enriched transcripts likely contain mo-
lecular markers unique for HESCs. For instance, SOCS-1,
an inhibitor of the STAT-3 signaling pathway, is enriched in
HESCs but not in MESCs, consistent with a recent report
suggesting a plausible reason why the response to LIF is
different between HESCs and MESCs (Schuringa et al.,
2002). Detailed evaluation of these genes will allow us to
address distinct molecular mechanisms that regulate stem-
ness in each species.
To date, a number of human ES cell lines have been
derived, although a handful of the lines are publicly
available (Reubinoff et al., 2000; Thomson et al., 1998).
In our human data sets, we used the H1 line, one of the
most accessible and well-characterized human ES lines,
because H1 cells can be maintained undifferentiated in
the absence of MEFs that provides us pure human RNA
(Xu et al., 2001). Since the possibility exists that differ-
ent human ES lines have different transcriptional profiles
and respond differently to the differentiation conditions,
comparisons of other types of HESCs remain to be de-
termined. The characterization of the molecular signature
of HESCs is a required and indispensable step for both
the basic studies as well as any potential clinical appli-
cation. Our study provides the first step, among many
other required approaches, to understand the biology of
pluripotent stem cells.
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